MERCK KGAA NAM.SP.ADR (F:MRKC) — Market Cap & Net Worth
Market Cap & Net Worth: MERCK KGAA NAM.SP.ADR (MRKC)
MERCK KGAA NAM.SP.ADR (F:MRKC) has a market capitalization of $17.07 Billion (€14.60 Billion) as of September 16, 2026. Listed on the F stock exchange, this Germany-based company holds position #1479 globally and #329 in its home market, demonstrating a -1.74% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MERCK KGAA NAM.SP.ADR's stock price €22.60 by its total outstanding shares 646211255 (646.21 Million). Also see MRKC total asset value for a full breakdown of the balance sheet.
MERCK KGAA NAM.SP.ADR Market Cap History: 2020 to 2026
MERCK KGAA NAM.SP.ADR's market capitalization history from 2020 to 2026. Data shows change from $19.90 Billion to $19.49 Billion (-0.40% CAGR). Also see MERCK KGAA NAM.SP.ADR (MRKC) cash conversion ratio for how efficiently the company converts equity into cash flow.
MERCK KGAA NAM.SP.ADR Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MERCK KGAA NAM.SP.ADR's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check MRKC stock price and chart for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.86x
MERCK KGAA NAM.SP.ADR's market cap is 0.86 times its annual revenue
Latest Price to Earnings (P/E) Ratio
6.95x
MERCK KGAA NAM.SP.ADR's market cap is 6.95 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $19.90 Billion | $17.53 Billion | $1.99 Billion | 1.13x | 10.01x |
| 2021 | $33.46 Billion | $19.69 Billion | $3.06 Billion | 1.70x | 10.95x |
| 2022 | $26.51 Billion | $22.23 Billion | $3.33 Billion | 1.19x | 7.97x |
| 2023 | $20.96 Billion | $20.99 Billion | $2.82 Billion | 1.00x | 7.42x |
| 2024 | $20.70 Billion | $21.16 Billion | $2.78 Billion | 0.98x | 7.45x |
| 2025 | $18.13 Billion | $21.10 Billion | $2.61 Billion | 0.86x | 6.95x |
Competitor Companies of MRKC by Market Capitalization
Companies near MERCK KGAA NAM.SP.ADR in the global market cap rankings as of September 16, 2026. Review MERCK KGAA NAM.SP.ADR tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to MERCK KGAA NAM.SP.ADR by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #518 globally with a market cap of $52.60 Billion USD.
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #631 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #636 globally with a market cap of $43.34 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #672 globally with a market cap of $40.69 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #518 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #631 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €16.00 |
| #636 | GALDERMA GROUP AG | NYSE:GALDY | $43.34 Billion | $37.18 |
| #672 | Haleon plc | NYSE:HLN | $40.69 Billion | $9.24 |
MERCK KGAA NAM.SP.ADR Historical Marketcap From 2020 to 2026
Between 2020 and today, MERCK KGAA NAM.SP.ADR's market cap moved from $19.90 Billion to $ 19.49 Billion, with a yearly change of -0.40%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €19.49 Billion | +7.50% |
| 2025 | €18.13 Billion | -12.41% |
| 2024 | €20.70 Billion | -1.26% |
| 2023 | €20.96 Billion | -20.92% |
| 2022 | €26.51 Billion | -20.78% |
| 2021 | €33.46 Billion | +68.18% |
| 2020 | €19.90 Billion | -- |
End of Day Market Cap According to Different Sources
On Apr 24th, 2026 the market cap of MERCK KGAA NAM.SP.ADR was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.07 Billion USD |
| MoneyControl | $17.07 Billion USD |
| MarketWatch | $17.07 Billion USD |
| marketcap.company | $17.07 Billion USD |
| Reuters | $17.07 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MERCK KGAA NAM.SP.ADR
Merck KGaA operates as a science and technology company in Germany and internationally. It operates through Life Science, Healthcare, and Electronics segments. The Life Science segment offers tools, chemicals, and equipment for academic labs, biotech, and pharmaceutical manufacturers, as well as the industrial sector. This segment offers science and lab solutions comprising reagents, consumables,… Read more